Search results
Is Bluebird Bio Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoPenny stocks -- companies whose shares are trading for $5 or less -- look cheap for a reason: They have encountered severe issues, and the market has...
Why Bluebird Bio Stock Flew Higher Than the Market Today
Motley Fool via Yahoo Finance· 3 months agoLike many biotechs, Bluebird Bio's (NASDAQ: BLUE) stock has been volatile over its lifetime. The...
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 3 months agoFor most stocks, a 25% cut in an analyst's target price following an earnings release would send...
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
Motley Fool via Yahoo Finance· 6 months agoNo stock is entirely risk-free, especially stocks like Bluebird Bio (NASDAQ: BLUE). The small-cap company's shares have plunged by 84% in the past three...
Should You Invest in Bluebird Bio Right Now?
Motley Fool via Yahoo Finance· 6 months agoBenjamin Graham and Warren Buffett may urge investors to buy when there's blood on the streets, but even the best advice has its limitations. In the case...
Better Buy: Bluebird Bio Vs. Novavax
Motley Fool via Yahoo Finance· 2 months agoIf there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to the biotech industry, it is...
2 Red Flags for Bluebird Bio Stock
Motley Fool via Yahoo Finance· 5 months agoThe past couple of years have been eventful for Bluebird Bio (NASDAQ: BLUE). In 2022, the gene-editing specialist earned approval for two therapies in...
bluebird bio, Inc. (NASDAQ:BLUE) is favoured by institutional owners who hold 58% of the company
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in bluebird bio, Inc. (NASDAQ:BLUE) should be aware of the most powerful shareholder...
Why Bluebird Bio Stock Dived Into the Red on Tuesday
Motley Fool via Yahoo Finance· 4 months agoInvestors were clearly feeling blue about Bluebird Bio (NASDAQ: BLUE) on Tuesday. Collectively, they traded the commercial-stage biotech stock down by...
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
Motley Fool· 1 year agoEditas Medicine (NASDAQ: EDIT) and Bluebird Bio (NASDAQ: BLUE) are both beaten-down gene-editing...